Compare ARK Genomic Revolution ETF (ARKG) vs Build A Bear Workshop Inc (BBW) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Build A Bear Workshop Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Build A Bear Workshop Inc trades at $34 (market cap $431.54M). The key difference: Build A Bear Workshop Inc pays a 2.67% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Build A Bear Workshop Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | BBW | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $75.85 |
52-Week Low | $23.09 | $29.84 |
Market Cap | — | $431.54M |
Enterprise Value | — | $530.98M |
Dividend Yield | — | 2.67% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Build-A-Bear Workshop (BBW) trades at $34.42, up 10.5% today, showing strong momentum despite a bearish technical outlook. The company demonstrates solid fundamentals with a P/E of 8.06 and robust profitability metrics including 35.87% ROE. Recent Q1 2026 earnings beat expectations with $1.03 EPS versus $0.76 estimate, though revenue guidance was revised downward. The company completed a planned CEO transition in June 2026 and maintains a debt-free balance sheet with consistent dividend payments.
BBW presents a compelling value opportunity with attractive valuation multiples and strong analyst support (72.7% buy ratings, $62.50 consensus target). However, near-term headwinds include consumer spending pressures and international expansion execution risks. The stock's 40% YTD decline creates potential for recovery if the company can successfully implement its four-pillar growth strategy in the second half of 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Build A Bear Workshop Inc
Build-A-Bear is a global retailer specializing in customizable stuffed animals. It offers an interactive make-your-own experience where customers choose, stuff, and dress their furry friends in-store or online.
Read more on BBW →
